Industry › Clinical Trials

Press Releases

冠科美博（Apollomics Inc.）宣佈完成和SPAC Maxpro合併，並在納斯達克上市

Mar 30, 2023 20:30 HKT/SGT

Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq

Mar 30, 2023 20:29 HKT/SGT

Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing

Mar 21, 2023 08:30 HKT/SGT

Singapore family cord blood bank Cryoviva upgrades to AXP II System for cord blood processing

Mar 21, 2023 08:00 HKT/SGT

亿胜生物公布2022年度业绩

Mar 08, 2023 20:30 HKT/SGT

億勝生物公布2022年度業績

Mar 08, 2023 20:29 HKT/SGT

Essex Bio-Technology Announces 2022 Annual Financial Results

Mar 08, 2023 20:28 HKT/SGT

亿胜生物与复宏汉霖签订治疗年龄相关性黄斑变性全球共同开发及独家许可协议之经修订协议

Feb 22, 2023 18:50 HKT/SGT

億勝生物與復宏漢霖簽訂治療年齡相關性黃斑變性全球共同開發及獨家許可協議之經修訂協議

Feb 22, 2023 18:49 HKT/SGT

Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration

Feb 22, 2023 18:48 HKT/SGT

Soligenix, Inc: Vital Vaccine Development Program has Potential to Address Future Marburg Virus Outbreaks

Feb 17, 2023 10:21 HKT/SGT

疫苗开发不断变化的全球格局：Novotech 和 Endpoints News 网络研讨会

Feb 16, 2023 08:00 HKT/SGT

疫苗開發不斷變化的全球格局：Novotech 和 Endpoints News 網絡研討會

Feb 16, 2023 08:00 HKT/SGT

백신 개발 발전의 글로벌 환경: 노보텍 및 엔드포인트 뉴스 웨비나

Feb 16, 2023 08:00 HKT/SGT

The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar

Feb 15, 2023 09:00 HKT/SGT

Novotech 全球報告：亞太地區穩健的 1 期試驗增長

Feb 13, 2023 06:00 HKT/SGT

노보텍 글로벌 보고서: 아시아 태평양 지역에서 1단계 임상시험의 확고한 성장

Feb 13, 2023 06:00 HKT/SGT

Novotech 全球报告：亚太地区稳健的 1 期试验增长

Feb 13, 2023 06:00 HKT/SGT

First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases

Feb 10, 2023 21:06 HKT/SGT

Novotech Global Report: Robust Phase 1 Trial Growth Across Asia Pacific

Feb 10, 2023 19:00 HKT/SGT